Innova Captab Ltd.

₹942.45

-8.3 (-0.9%)

INNOVACAP Share Price

Pharmaceuticals & Biotechnology

As on June 12, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 5,382 Cr

P/E Ratio38.27

Dividend Yield0.02 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	917.61	Bullish
10-DMA	890.83	Bullish
20-DMA	875.64	Bullish
50-DMA	805.57	Bullish
100-DMA	745.58	Bullish
200-DMA	768.9	Bullish

Historical Performance

1 Year

-0.3%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	16,300	12,437	10,813	9,264	8,005
Total Expenditure	13,984	10,575	9,269	8,127	7,045
Other Income	187	120	125	92	29
Operating Profit	2,503	1,982	1,669	1,228	989
Interest	169	24	215	200	57
Depreciation	452	248	160	111	75
Profit Before Tax	1,883	1,710	1,295	918	857
Consolidated Net Profit	1,409	1,283	943	680	638
Adjusted EPS	25	22	16	14	13

Compounded Sales Growth

10 Years:35.6

5 Years:31.7

3 Years:12

TTM:5.6

Compounded Profit Growth

10 Years:47.9

5 Years:32.6

3 Years:15.7

TTM:1.9

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:3.9

Return on Equity

10 Years:N/A

5 Years:13.3

3 Years:16.5

last year:24.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	572	572	572	480	120
Total Reserves	10,336	9,022	7,737	2,285	1,966
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,506	2,557	2,045	1,942	881
Other Current Liabilities	692	773	580	205	283
Short Term Borrowings	993	656	238	979	1,201
Total Liabilities	18,581	15,916	13,294	7,482	6,122
Capital Work in Progress	155	225	3,408	215	---
Long Term Loans & Advances	164	68	220	1,011	288
Currents Investments	413	---	---	---	---
Short Term Loans and Advances	1,140	781	801	276	501
Total Current Assets	9,451	7,191	6,082	4,425	4,000
Total Assets	18,581	15,916	13,294	7,482	6,122
Adjusted Book Value	191	168	145	58	43

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 38.27, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 31.9%, indicating sustained price appreciation.
The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹2503 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹16300 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1055375.1

No. of Shares: 1120 (Approx)

Performance:5.5%

P/L: ₹55375.1

NIFTY Performance: -4.4%

1 day Top Gainers